A DNA test to detect esophageal precancer.

Empowering clinicians through early detection to prevent esophageal cancer before it develops.

learn about lucid
  • NEWS STORY
New technology helps screen SC firefighters for pre-cancer
Read article
  • NEWS STORY
New test can help with early screening for esophageal cancer
Read article
  • NEWS STORY
Chesapeake firefighters attack an increased cancer risk with early detection screening
Read article

precancer detection

Early detection powered by targeted Next Generation Sequencing

The groundbreaking EsoGuard DNA test is changing the way esophageal precancer is detected. Now disease can be identified in a simple office-based visit without endoscopy.

Learn About ESOGUARD

Patient Stories

Don M.
Patient

"If you're seeing symptoms of reflux, a chronic cough, ask your doctor to screen you. Don't take reflux lightly. Reflux can equal Barrett's, can equal esophageal cancer."

Clinician testimonials

Srinadh Komanduri, MD, MS FAGA, FASGE
Associate Chief, Division of Gastroenterology and Hepatology
Northwestern University

"Providing EsoGuard to my patients is paramount because it empowers early detection of Barrett’s esophagus, non-invasively. By offering this test, we can catch potential issues at their earliest stages, allowing for timely intervention and improved patient outcomes."

Host a #CheckYourFoodTube Esophageal Precancer Testing Event

Firefighters have a 62% increased risk of developing esophageal cancer and 39% increased risk of dying of the disease.1 The EsoGuard DNA test offers early detection for those at increased risk, which is why we partner with fire departments across the country to host convenient group screening events.

Request an event

Careers

Join the team revolutionizing early detection

At Lucid Diagnostics, we believe early detection will make esophageal cancer a disease of the past. We're using next generation sequencing to fundamentally change the way esophageal precancer is detected. Join a diverse and inclusive team where collaboration and mutual respect are the foundation of our success. 

View Positions

Press releases

Read the latest news from Lucid Diagnostics
March 10, 2025

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on March 24, 2025

Read article
March 5, 2025

Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering

Read article
March 4, 2025

Lucid Diagnostics Announces $15.3 Million Registered Direct Offering

Read article
February 27, 2025

Renowned Investigators Awarded $8 Million NIH Grant to Study Lucid Diagnostics' EsoGuard® in At-Risk Patients without Symptomatic GERD

Read article

Contact us

Get in touch with our team
contact us
References:
1. IAFF date 1.1.2002 to 3.31.2017—NIOSH Research